MICROTECH MED-B 02235·

Gross margin 46.82%--47.20%0.38%47.65%0.45%52.91%5.25%54.09%1.19% Net margin -31.80%---20.19%11.62%-49.37%29.18%-18.26%31.11%6.08%24.34% ROE -2.14%---1.58%0.56%-6.07%4.48%-3.20%2.87%1.99%5.19% ROA -2.07%---1.53%0.54%-5.79%4.26%-2.94%2.85%1.74%4.68% Revenue growth ----14.66%--45.86%31.20%36.48%9.38%91.19%54.71% Attributable profit growth ----27.23%---256.75%283.97%49.51%306.26%163.61%114.10% Debt-to-assets 3.54%--3.58%0.04%4.53%0.95%8.00%3.48%12.81%4.81% Current ratio 27.12--27.500.3821.675.8411.4110.266.395.03 Operating cash flow / net profit 0.92--3.402.481.222.171.910.690.811.10 Operating cash flow / revenue -29.20%---68.55%39.35%-60.42%8.13%-34.91%25.51%4.93%39.84%

Gross margin 51.66%--57.71%6.06% Net margin -0.93%--9.72%10.66% Revenue growth ----68.40%-- Attributable profit growth ----1856.59%-- Debt-to-assets ----12.92%-- Current ratio ----6.19--

Revenue 151.40M--173.61M14.66%253.23M45.86%345.62M36.48%660.79M91.19% Other income and gains 29.06M--137.91K99.53%18.24K86.77%163.19K794.54%239.49K46.76% Gross profit 70.88M--81.94M15.59%120.67M47.27%182.85M51.53%357.42M95.48% Selling and distribution expenses 52.26M--116.70M123.32%205.02M75.68%207.14M1.03%223.05M7.68% Administrative expenses 41.48M--41.53M0.13%45.60M9.79%42.15M7.57%48.29M14.58% Net finance costs 17.00K--85.40M502258.72%75.04M12.14%71.56M4.63%29.18M59.23% Income tax ----1.51K--163.62K10755.18%30.96K81.08%248.98K704.14% Operating profit -48.14M---120.44M150.21%-199.89M65.96%-134.71M32.61%11.22M108.33% Profit before tax -48.15M---35.04M27.23%-124.85M256.30%-63.15M49.42%40.40M163.98% Net profit -48.15M---35.04M27.23%-125.02M256.75%-63.12M49.51%40.15M163.61% Net profit attributable to owners -48.15M---35.04M27.23%-125.02M256.75%-63.12M49.51%40.15M163.61%

Revenue 245.93M--414.14M68.40% Cost of sales 118.89M--175.13M47.30% Gross profit 127.04M--239.01M88.14% Selling and distribution expenses 92.81M--117.96M27.10% Administrative expenses 18.20M--30.59M68.06% Net finance costs 22.67M--12.75M43.77% Income tax 4.54K--70.13K1443.85% Operating profit -2.40M--43.84M1922.88% Profit before tax -2.30M--40.34M1856.17% Net profit -2.29M--40.27M1856.59% Net profit attributable to owners -2.29M--40.27M1856.59%

Cash and cash equivalents 2.15B--2.05B4.85%1.89B7.85%1.70B10.00%1.51B11.22% Trade and bills receivables 27.77M--49.26M77.37%73.23M48.68%117.82M60.88%144.70M22.82% Inventories 34.16M--67.34M97.09%42.11M37.46%50.81M20.64%79.07M55.62% Total current assets 2.23B--2.18B2.52%2.02B7.07%1.90B5.85%1.81B5.07% Total assets 2.33B--2.29B1.50%2.16B5.90%2.15B0.58%2.31B7.64% Total current liabilities 82.34M--79.16M3.86%93.38M17.96%166.93M78.76%283.18M69.64% Total liabilities 82.48M--82.07M0.50%97.70M19.05%171.72M75.77%295.97M72.35% Equity attributable to owners 2.25B--2.21B1.54%2.06B6.82%1.97B4.19%2.01B2.01% Total equity 2.25B--2.21B1.54%2.06B6.82%1.97B4.19%2.01B2.01%

Cash and cash equivalents ----1.54B-- Trade and bills receivables ----141.32M-- Inventories ----102.72M-- Total current assets ----1.82B-- Total assets ----2.34B-- Total current liabilities ----293.40M-- Total liabilities ----302.20M-- Equity attributable to owners ----2.04B-- Total equity ----2.04B--

Net cash from operating activities -44.22M---119.01M169.16%-153.00M28.56%-120.65M21.14%32.61M127.03% Net cash from investing activities 97.69M---389.44M498.66%-540.70M38.84%121.16M122.41%-360.93M397.91% Net cash from financing activities 1.57B---20.57M101.31%-23.46M14.06%-33.15M41.28%56.68M270.99% Net change in cash 1.63B---501.93M130.84%-718.81M43.21%-26.76M96.28%-288.04M976.34%